1. METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway
   Yi Wang et al, 2023, Frontiers in Pharmacology CrossRef
2. Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota
   Junshu Li et al, 2023, Cell & Bioscience CrossRef
3. Targeting key RNA methylation enzymes to improve the outcome of colorectal cancer chemotherapy (Review)
   Chiyun Shao et al, 2023, International Journal of Oncology CrossRef
4. Clostridium butyricum inhibits epithelial–mesenchymal transition of intestinal carcinogenesis through downregulating METTL3
   Kexin Zhang et al, 2023, Cancer Science CrossRef
5. Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics
   Yang Yang et al, 2024, Cancer Letters CrossRef
6. The diverse role of RNA methylation in esophageal cancer
   Wangyang Meng et al, 2023, Acta Biochimica et Biophysica Sinica CrossRef
7. Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
   Ya-Nan Qi et al, 2023, Journal of Hematology & Oncology CrossRef
8. New insights into the regulation of METTL3 and its role in tumors
   Qiu Jin et al, 2023, Cell Communication and Signaling CrossRef
9. METTL3-mediated m 6 A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis
   Zhiyang Zhou et al, 2023, Epigenetics CrossRef
10. PFKP is upregulated in 5-fluorouracil-resistant patients and suppresses the antitumor activity of 5-fluorouracil in colorectal cancer in vitro and in vivo
    Lili Deng et al, 2023, Journal of Chemotherapy CrossRef
11. Desulfovibrio desulfuricans and its derived metabolites confer resistance to FOLFOX through METTL3
    Guifang Li et al, 2024, eBioMedicine CrossRef